The University of Rostock is a public university located in Rostock, Mecklenburg-Vorpommern, Germany. Founded in 1419, it is the third-oldest university in Germany. It is the oldest university in continental northern Europe and the Baltic Sea area, and 8th oldest in Central Europe.

During the past decade, University of Rostock conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Rostock" #1 sponsor was "University of Rostock" with 8 trials, followed by "Goethe University" with 2 trials sponsored, "Max Dieterich" with 2 trials sponsored, "medac GmbH" with 2 trials sponsored and "AO Clinical Investigation and Publishing Documentation" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rostock" #1 collaborator was "University of Rostock" with 3 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Alzheimer Forschungsinitiative e.V. (AFI)" with 1 trials as a collaborator and "B.Braun Vascular Systems, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "University of Rostock" are "Acute Myeloid Leukemia" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Leukemia" (2 trials) and "ATRIAL FIBRILLATION, Syncope" (1 trials). Many other conditions were trialed in "University of Rostock" in a lesser frequency.

Most popular intervention types in "University of Rostock" are "Drug" (21 trials), "Device" (11 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Sevoflurane" (2 trials), "Treosulfan" (2 trials), "250ml HES 6%" (1 trials) and "9% NaCl 500ml" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Rostock" are 35 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Rostock". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in University of Rostock, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Rostock, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

University of Rostock has several departments that took part in Clinical trials: "Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock" - 11 trials, "University of Rostock, Department of Neurology" - 8 trials, "Universitätsklinikum Rostock Zentrum für Nervenheilkunde" - 4 trials, "Universitätsmedizin Rostock; Klinik und Poliklinik für Dermatologie und Venerologie" - 2 trials, "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin" - 2 trials, "Department of Anesthesia and Intensive Care Medicine, University of Rostock" - 2 trials, "Universitätsklinikum Rostock, Kinder- und Jugendklinik, Päd. Hämatologie und Onkologie" - 2 trials, "Department of Orthopedics, University Medicine Rostock" - 2 trials, "Department of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock" - 2 trials